PPARG and cancer: Saiki et al. reported that as compared to the cells with normal or lower expression of PPARγ, pioglitazone at the concentration ranging from 100 to 300 μM induced significant anti‐survival and antiproliferative effects on PPARγ‐expressing cancer cells (Saiki et al., 2006).